We are analyzing https://link.springer.com/chapter/10.1007/978-3-030-35805-1_8.

Title:
Epigenetics of Circulating Tumor Cells in Breast Cancer | SpringerLink
Description:
Liquid biopsy based on the analysis of circulating tumor cells (CTCs) has emerged as an important field of research. Molecular characterization of CTCs can provide insights into cancer biology and biomarkers for the clinic, representing a non-invasive powerful tool...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, google, scholar, cancer, article, cas, breast, tumor, central, circulating, cells, res, methylation, dna, clin, metastasis, noncoding, patients, human, med, epigenetic, expression, analysis, epigenetics, sci, nat, cell, metastatic, gene, rnas, clinical, diazlagares, rna, suppressor, chem, wang, httpsdoiorg, disease, chapter, detection, liu, rev, long, httpsdoiorgccr, microrna, research, natl, esteller, oncology, oncol,

Topics {✒️}

locked-nucleic-acid-incorporated dna probes roche-chus joint unit month download article/chapter serum mir-21/mir-155/mir-365 patient-derived xenograft models reactivates tumor-suppressive pathways organ-confined prostate adenocarcinoma van der burg circulating tumor cells—mishctc angel diaz-lagares methyl-group metabolism genes brca1-deficient breast cancer cell-free tumor dna chapter bao-caamano rodriguez-casanova c-met drives metastasis mir-10b expression mir-221 promotes stemness early-stage lung cancers paired primary tumours poor progression-free survival noncoding rna malat1 chromatin signature reveals advanced breast cancer privacy choices/manage cookies circulating tumor cells microrna expression profiles solid tumor patients sanchez-martin rm genome-wide profiling �xunta de galicia” long noncoding rnas health research institute device instant download tumor suppressor gene metastatic breast cancer author reply e5–6 circulating tumour cells garcia puche jl van laere sj cell-free dna pro-metastatic phenotype human genome enriched tumor cells circulate natl cancer inst promote cancer metastasis meta-analysis based breast cancer cells breast cancer progression human primary tumors

Schema {🗺️}

ScholarlyArticle:
      headline:Epigenetics of Circulating Tumor Cells in Breast Cancer
      pageEnd:134
      pageStart:117
      image:https://media.springernature.com/w153/springer-static/cover/book/978-3-030-35805-1.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Circulating Tumor Cells in Breast Cancer Metastatic Disease
         isbn:
            978-3-030-35805-1
            978-3-030-35804-4
         type:Book
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Aida Bao-Caamano
            affiliation:
                  name:University Clinical Hospital of Santiago (CHUS/SERGAS)
                  address:
                     name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aitor Rodriguez-Casanova
            affiliation:
                  name:University Clinical Hospital of Santiago (CHUS/SERGAS)
                  address:
                     name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
                     type:PostalAddress
                  type:Organization
                  name:Health Research Institute of Santiago de Compostela
                  address:
                     name:Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Angel Diaz-Lagares
            affiliation:
                  name:University Clinical Hospital of Santiago (CHUS/SERGAS)
                  address:
                     name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
                     type:PostalAddress
                  type:Organization
                  name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC)
                  address:
                     name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      keywords:Epigenetics, DNA methylation, Noncoding RNAs, Circulating tumor cells, CTC, Liquid biopsy, Breast cancer
      description:Liquid biopsy based on the analysis of circulating tumor cells (CTCs) has emerged as an important field of research. Molecular characterization of CTCs can provide insights into cancer biology and biomarkers for the clinic, representing a non-invasive powerful tool for monitoring breast cancer metastasis and predict the therapeutic response. Epigenetic mechanisms play a key role in the control of gene expression and their alteration contributes to cancer development and progression. These epigenetic modifications in CTCs have been described mainly related to modifications of the DNA methylation pattern and changes in the expression profile of noncoding RNAs. Here we summarize the recent findings on the epigenetic characterization of CTCs in breast cancer and their clinical value as tumor biomarkers, and discuss challenges and opportunities in this field.
      datePublished:2020
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Circulating Tumor Cells in Breast Cancer Metastatic Disease
      isbn:
         978-3-030-35805-1
         978-3-030-35804-4
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University Clinical Hospital of Santiago (CHUS/SERGAS)
      address:
         name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
         type:PostalAddress
      name:University Clinical Hospital of Santiago (CHUS/SERGAS)
      address:
         name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
         type:PostalAddress
      name:Health Research Institute of Santiago de Compostela
      address:
         name:Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
         type:PostalAddress
      name:University Clinical Hospital of Santiago (CHUS/SERGAS)
      address:
         name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
         type:PostalAddress
      name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC)
      address:
         name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Aida Bao-Caamano
      affiliation:
            name:University Clinical Hospital of Santiago (CHUS/SERGAS)
            address:
               name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
               type:PostalAddress
            type:Organization
      name:Aitor Rodriguez-Casanova
      affiliation:
            name:University Clinical Hospital of Santiago (CHUS/SERGAS)
            address:
               name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
               type:PostalAddress
            type:Organization
            name:Health Research Institute of Santiago de Compostela
            address:
               name:Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
               type:PostalAddress
            type:Organization
      name:Angel Diaz-Lagares
      affiliation:
            name:University Clinical Hospital of Santiago (CHUS/SERGAS)
            address:
               name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
               type:PostalAddress
            type:Organization
            name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC)
            address:
               name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
      name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
      name:Roche-Chus Joint Unit, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
      name:Cancer Epigenomics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
      name:Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(628)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js

5.53s.

LINK . SPRINGER . COM {}